The Cancer Prevention and Research Institute of Texas (CPRIT) awarded more than $9 million in research grants to Texas A&M University. Of the $9,057,870 in funding from CPRIT, more than $7.7 million is for academic research and $1.35 million is for a prevention grant. Eight grants were awarded by CPRIT. The largest was $5,793,075 to the recently established Center for Advanced Microscopy and Image Informatics (CAMII) in the Institute of Biosciences and Technology, College of Medicine.
Read MoreTags: TAMU, Biotechnology Vendor Fair, Texas A&M Research, Texas A&M Life Science Funding, biotech vendor show, Texas A&M, Research equipment, cancer researchers, cancer research grant, laboratory suppliers, BioResearch Product Faire, medical marijuana, colon cancer
In June, the Texas legislature unanimously passed Charlie’s Law which allows patients with chronic and terminal diseases access to experimental stem cell interventions. The law, named after the late Texas State representative Charlie Howard, is the first of its kind in the U.S.
Read MoreTags: Stem cell research, Human Stem Cell, Texas Medical Center, Biomedical Reearch, TAMU, tmc, Biotechnology Vendor Fair, Texas A&M Research, Texas A&M Life Science Funding, biotech vendor show, Texas A&M, Research equipment, laboratory suppliers, BioResearch Product Faire, pollution
In the aftermath of Hurricane Harvey, a group of researchers will study the effects of the pollution stirred up by the flooding. Scientists from Texas A&M, College Station will conduct four environmental research projects thanks to a five year, $10 million grant from the National Institute of Environmental Health Sciences (NIEHS) Superfund Research Program. All four projects will stem from a case study of Galveston Bay and the Houston Ship Channel that examines the chemicals found within the sediment. These studies are designed to improve our understanding of the complexities of hazardous chemicals exposure and its negative impacts on health.
Read MoreTags: environmental contaminants, TAMU, Biotechnology Vendor Fair, Texas A&M Research, Texas A&M Life Science Funding, biotech vendor show, Texas A&M, Research equipment, laboratory suppliers, BioResearch Product Faire, pollution
The chancellor’s office of Texas A&M University (TAMU) recently funded a $5 million initiative to support mass spectrometry research. As part of this initiative a $1 million grant from the Texas A&M University Research Development Fund will be used to develop a shared mass spectrometry core facility and buy two new mass spectrometers for the College Station campus. One will be a gas chromatography combustion/pyrolysis isotope ratio mass spectrometer and the other will be a high resolution isotope ratio mass spectrometer for clumped isotopes.
Read MoreTags: TAMU, Biotechnology Vendor Fair, Texas A&M Research, Texas A&M Life Science Funding, biotech vendor show, Texas A&M, Research equipment
Currently, doctors have two options when a patient needs a facial bone replaced due to injury or illness, such as cancer. They can take a bone from another part of the body and graft it into place. However, implant morbidity and complications caused by the trauma of multiple surgeries make this option less than ideal. The second option is to graft synthetic materials to the site. However, from time of injury to delivery of the custom implant takes about three to four weeks, which reduces the chances of the patient healing properly. But now a new technology being developed by researchers at Texas A&M’s College of Dentistry may revolutionize the treatment process.
Read MoreTags: Biomedical Equipment, Texas A&M University, Biotechnology Vendor Fair, Texas A&M Research, Texas A&M Life Science Funding, Texas A&M, biomedical researh, 3D printing, Biotechnology trade show
Often growing up as a child you hear, “eat your veggies if you want to grow up to be big and strong.” With new research on triple negative breast cancer, that old saying might have to change to "eat your veggies if you want to keep cancer away". Recently, at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, Mandip Sachdeva announced: "We are confident that the compounds we are currently working with are an effective treatment for triple-negative breast cancer. These compounds are safer for the patient than current treatments available".
Tags: Bioscience research, cancer research, Texas A&M University, Texas, 2012, Cancer Treatment, Cancer, College Station, BioResearch Product Faire Event, Texas A&M Research, Texas A&M Life Science Funding, TX, Texas A&M